看多
Delmar climbs, despite first quarter reported losses
After reporting first quarter losses of 9.9 million dollars, Delmar is poised to hit a bull run, likely due to continued global interest is pursuing medical research.
An old resistance level is reversing to support as sellers struggle to push prices down to previous levels. Ive laid out a long strategy to capitalize on short term growth.
An old resistance level is reversing to support as sellers struggle to push prices down to previous levels. Ive laid out a long strategy to capitalize on short term growth.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。